The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting
Launched by REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY · Dec 31, 2020
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
Following enrollment, patients will undergo ovarian stimulation and oocyte retrieval per routine as previously consented to at the clinic. IVF stimulation protocol will be at the discretion of the patient's individual provider, per routine. Intracytoplasmic Sperm Injection (ICSI) will be performed and embryos will be cultured to the blastocyst stage per routine. There are no changes to the embryology care itself, the only difference within the study is the CO2 level within the incubator pending the patient's randomization.
Gender
FEMALE
Eligibility criteria
- Major Inclusion Criteria for participants:
- • 1. Patients undergoing IVF stimulation cycle with plan for subsequent FET
- Major Exclusion Criteria for participants:
- • 1. All patients who do not voluntarily give their written consent for participation
- • 2. Male partner with \<100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable)
- • 3. Use of surgical procedures to obtain sperm
About Reproductive Medicine Associates Of New Jersey
Reproductive Medicine Associates of New Jersey (RMANJ) is a leading fertility clinic dedicated to advancing reproductive health through innovative clinical practices and cutting-edge research. With a team of highly skilled specialists, RMANJ offers comprehensive services in assisted reproductive technology, including in vitro fertilization (IVF), egg freezing, and fertility preservation. The organization is committed to providing personalized care and leveraging the latest scientific advancements to optimize patient outcomes. Through its robust clinical trial initiatives, RMANJ aims to contribute to the ongoing evolution of reproductive medicine, fostering new therapies and improving access to effective fertility treatments for individuals and couples facing reproductive challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basking Ridge, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials